A highly annotated database of genes associated with platinum resistance in cancer

Platinum-based chemotherapy, including cisplatin, carboplatin, and oxaliplatin, is prescribed to 10-20% of all cancer patients. Unfortunately, platinum resistance develops in a significant number of patients and is a determinant of clinical outcome. Extensive research has been conducted to understan...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Dongqing, Savage, Sara R., Calinawan, Anna P., Lin, Chenwei, Zhang, Bing, Wang, Pei, Starr, Timothy K., Birrer, Michael J., Paulovich, Amanda G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602037/
https://www.ncbi.nlm.nih.gov/pubmed/34645978
http://dx.doi.org/10.1038/s41388-021-02055-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602037/
https://www.ncbi.nlm.nih.gov/pubmed/34645978
http://dx.doi.org/10.1038/s41388-021-02055-2

Ejemplares similares